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jc.2013.0Abstract A simple and rapid technique based on salting out assisted solvent extraction was devel-
oped for extraction of atorvastatin from serum sample and high performance liquid chromatogra-
phy–UV was used for its detection. In the present study, 1.0 mL serum was extracted by 0.5 mL of
acetonitrile and some parameters that can affect extraction such as type and volume of extraction
solvent, type of salt, and pH were optimized. Under optimized experimental conditions, the calibra-
tion curve was found to be linear in the range of 0.001–10 ng mL1 in human serum and the cor-
relation coefﬁcient (R2) and the limits of detection were >0.99 and 0.0005 ng mL1, respectively.
The accuracy of the method in terms of average recovery of the compound in spiked serum and
water samples was better than 90%.
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7.057pyrrole-1-heptanoic acid calcium salt (Fig. 1.) belongs to the
group of statins and it is a second generation HMG-CoA
reductase inhibitor recently approved for clinical use as a cho-
lesterol lowering agent (Bullen et al., 1999). These drugs inhibit
the rate limiting key enzyme known as 3-hydroxy-3-methyl-
glutarylcoenzyme A (HMG-CoA) reductase involved in cho-
lesterol biosynthesis (Janardhanan et al., 2012).
More than 90% of atorvastatin is bound to plasma pro-
teins. About 70% of the total plasma HMG-CoA activity is
attributed to active metabolites of atorvastatin, even if their
concentrations are very low. Information about the actual
plasma concentration of atorvastatin is of interest in pharma-
cokinetic studies and investigations of the mechanisms of
drug–drug interactions (Hermann et al., 2005). To date several
HPLC-UV and LC-MS methods have been developed for theing Saud University.
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Figure 1 Structure of atorvastatin calcium salt (2:1).
88 J. Hassan, S.H. Bahraniquantiﬁcation of atorvastatin in different matrices (Shah et al.,
2011; Farahani et al., 2009; Novakova et al., 2008). A conve-
nient sample-preparation procedure should isolate the analytes
from the complex matrix while removing endogenous interfer-
ing substances. This is often the most time-consuming, critical
step of analysis. Sample preparation can include clean-up pro-
cedures for very complex (dirty) samples. The analytes should
be pre-concentrated in order to increase the sensitivity and the
selectivity of the method. Drug analysis in human urine and
blood plasma is often complicated by low analyte concentra-
tions, by complex sample matrices, and by limited sample vol-
umes available for the determinations (normally 0.5–1.0 ml for
plasma). Because of this, sample preparation is crucial in drug
analysis and includes both analyte preconcentration and sam-
ple clean-up. The procedures for sample preparation of atorva-
statin have in most cases included LLE (liquid–liquid
extraction), and SPE (solid-phase extraction). However, the
conventional LLE procedures are time consuming, generally
labor intensive and require large quantities of expensive, toxic
and environmentally unfriendly organic solvents. SPE often
suffered from the plugging of cartridge and consumption of
appreciable amount of toxic solvents at the elution step. In or-
der to overcome these problems, simple, inexpensive liquid-
phase microextraction (LPME) was introduced recently.
LPME is a solvent-minimized sample pretreatment procedure
of LLE, in which only several lL of solvent are required to
concentrate analytes from various samples rather than hun-
dreds of mL needed in traditional LLE. Salting-out is a process
of addition of electrolytes to an aqueous phase in order to in-
crease the distribution ratio of a particular solute. Salting-out
assisted liquid/liquid extraction (SALLE) with water miscible
organic solvent has shown its distinctive advantages in bioan-
alytical research (Hassan and Farahani, 2011). SALLE is com-
parable with LLE for extract cleanness (Lovin et al., 2003;
Nagaosa and Sakata, 1998; Jia et al., 2006; Myasein et al.,
2009). SALLE is a more green technique compared with com-
mon sample preparation techniques used for bioanalysis. Ace-
tonitrile was found as a promising extracting solvent owing to
its compatibility with reversed-phase HPLC. However, there
are a few methods available utilizing sample preparation by
salting out phase separation and HPLC.
The aim of the work was to develop a fast, easy and low-
volume (for both sample and organic solvent volume) sample
preparation technique convenient for routine preparation of
biological samples containing atorvastatin. Advantages ofsalting-out with acetonitrile have been demonstrated, includ-
ing the ease of biological sample clean-up as well as analyte
enrichment.
2. Experimental
2.1. Chemicals and reagents
Pure reference standard of atorvastatin with chemical purity of
>99.3% kindly supplied from Farayand Chemi Hackim Com-
pany (Qazvin, Iran) was used without any further puriﬁcation.
HPLC grade acetonitrile, ammonium acetate, and methanol
were of analytical grade supplied by Merck (Darmstadt,
Germany). Stock solution of atorvastatin (1000.0 mg L1)
was prepared in methanol. The working standard solutions
of atorvastatin were prepared by diluting an appropriate vol-
ume of stock solution. All the standard solutions were stored
at 4 C in the refrigerator.
2.2. Instrumentation
The analytical chromatographic system consisted of an Agilent
1200 series vacuum degasser (G1322A), an automatic sample
injector, a quaternary pump (1200 series G1311-90011 Quat-
Pump), a variable wavelength detector (VWD-G1314A), a
column oven (G1313A), (all from Agilent Technologies, Palo
Alto, USA), and a Symmetric C18 column 5 lm,4.6 mm i.d.,
250 mm column length with guard column (Waters Corpora-
tion, Massachusetts, U.S.A.,) and controlled by a computer
running Chem Station software (Agilent Technologies).
Mobile phases were ﬁltered through a Millipore 0.22-lm mem-
brane ﬁlter before use. The column was stabilized at 25 ± 2 C
(room temperature) for 1 h before chromatography. A ﬂow-
rate of 1.0 mL min1 was applied in laboratory temperature
of 25 (±2) C. The mobile phase was CH3COONH4 buffer
in water (Adjusted pH= 3.0 ± 0.05 with orto phosphoric
acid)-acetonitrile (50: 50, v/v) and the detection wavelength
was 246 nm.
2.3. Extraction method
Atorvastatin was extracted from 1.0 mL of sample by adding
0.5 mL of acetonitrile, 0.5 mL of ammonium acetate buffer
(pH = 4) into a 2 mL polypropylene micro-centrifuge tube,
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Figure 2 Effect of the volume of acetonitrile on the extraction of
atorvastatin from serum sample. Extraction conditions: sample
volume, 1.0 mL; pH= 4; concentration of atorvastatin,
1000 ng mL1, 0.30 g of magnesium chloride.
Determination of atorvastatin in human serum by salting out assisted solvent extraction and reversed-phase 89and vortexed for 30 s. Finally, 0.3 g magnesium chloride was
added and mixed for phase separation. The supernatant ﬂuid
was transferred to another 1.5 ml polypropylene micro centri-
fuge tube and 20 lL of the solution was injected into the
HPLC column.0
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Figure 3 Effect of the type of pH on extraction of atorvastatin
from serum sample. Extraction conditions: sample volume,
1.0 mL; concentration of atorvastatin, 1000 ng mL1, 0.30 g of
salt.3. Result and discussion
The theory of SALLE is similar to that of LLE. The ﬁnal con-
centration of the analyte in the sample solution (Cf) is as
follows:
Cfðlg mL1Þ ¼
CexeqVex
VsamEr
ð1Þ
The extraction recovery (Er) was deﬁned as the total analyte
amount which was extracted to the extracting phase:
Er ¼
CexeqVex
VsamCini
ð2Þ
The preconcentration factor (Pf), deﬁned as the ratio of con-
centrations (signals) after and before extraction:
Pf ¼
Cexeq
Cini
ð3Þ
The enrichment factor (Ef), deﬁned as the ratio of volume of
sample and volume of extraction solvent:
Ef ¼ Vsam
Vex
ð4Þ
The enhancement factor (En), deﬁned as the ratio of slope of
calibration curves after and before (direct) microextraction:
En ¼ Saft
Sdir
ð5Þ
where, Cexeq (lg mL
1) is the ﬁnal concentration of analyte in
the extracting phase, Cini is the initial concentration of analyte
in the sample, and Vex (mL) is the ﬁnal (separated) volume of
the extracting phase, Er is the extraction recovery and Vsam
(mL) is the volume of the sample, respectively.3.1. Effect of extraction solvent
The miscibility of solvent and aqueous sample solution is the
main point of selection for extraction solvent. Therefore, ace-
tone, acetonitrile and methanol were introduced for this pur-
pose. Acetone cannot deprontonise serum, and methanol was
not separate after the addition of salt, thus acetonitrile was se-
lected as the solvent in the subsequent extractions.
3.2. Effect of phase volume ratio
To investigate of volume of acetonitrile on extraction efﬁciency
a series sample solution (serum) containing 1000.0 ng mL1 of
atorvastatin was extracted by 0.5, 1.0, 1.5 and 2.0 mL of ace-
tonitrile, separately. The results show the peak area (concen-
tration) of the analytes decreased with the increasing volume
of acetonitrile, but extraction efﬁciency (peak area * volume
of acetonitrile) was nearly constant. (Fig. 2.).
3.3. Effect of salting-out on phase separation
There have been limited reports on SALLE with water misci-
ble organic solvents and inorganic salts as the salting-out
agent, for the separation, isolation and preparation of biolog-
ical samples. Although it is well known that acetonitrile is mis-
cible with water in any proportion at room temperature,
addition of salt signiﬁcantly reduced the mutual miscibility,
even resulting in phase separation of acetonitrile from the
aqueous phase. Three inorganic salts that included sodium sul-
fate, sodium chloride and magnesium chloride were examined
in SALLE. Here magnesium chloride is used as a salting-out
reagent due to its high ionic strength per unit concentration
in the aqueous phase and good extraction efﬁciency.
3.4. Effect of pH of sample solution
The effect of sample pH was evaluated in the range of 1–8 and
the results are shown in Fig. 3. The pH of the sample solution
had a minor effect on the extraction efﬁciency. At pH lower
than 2, it is expected that the amine groups are ionized to
the ammonium form, and also at pH > 4 extraction was
decreased.
Table 1 Figures of merit obtained for direct calibration and after the SALLE–HPLC-UV determination of atorvastatin in human
plasma.
Matrix Regression equation R2 Dynamic linear range (lg mL1) LOD (lg mL1) Enhancement factor
Acetonitrile Area = 5.1 C + 0.03 0.9997 0.01–100 0.004 1
Water Area = 57.1 C + 2 0.9989 0.001–10 0.0005 11
Serum Area = 57.5 C + 0.7 0.9980 0.001–10 0.0005 11
Table 2 Accuracy, precision and analytical recovery obtained for atorvastatin by SALLE method.
Compound Spiked level (ng mL1) Tap water Serum
Found ± SDa (ng mL1) Recovery ± RSDb (%) Found ± SD (ng mL1) Recovery ± RSD (%)
Atorvastatin – <LOD – <LOD –
4.0 3.90 (±0.3) 98.5 (±4) 4.05 (±0.4) 101 (±10)
10.0 9.95 (±0.6) 99.5 (±6) 9.90 (±0.3) 99 (±3)
a SD= Standard deviation.
b RSD= Relative standard deviation; n= 3.
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In order to validate the developed SALLE method, linearity,
correlation coefﬁcient, detection limits, and repeatability were
tested using spiked samples. Standard calibration curve of
atorvastatin in acetonitrile, blank serum sample, and in blank
water sample was prepared by the external standard method
and the obtained calibration curves were compared with each
other. As can be seen in Table 1, there are no differences be-
tween slope of calibration curves in serum and water sample
matrices. Peak identiﬁcation was made by comparing the
retention times and spectra of samples with those of standards
and the correlation coefﬁcients (R2) of >0.99 were obtained.
The limit of detection (LOD) based on signal to noise of three
limits of detection obtained was 0.5 ng mL1 for serum matri-
ces. The limit of quantiﬁcation (LOQ) was deﬁned as the low-
est concentration of an analyte that can be determined with
acceptable precision and accuracy under the stated conditions
of the test (Table 1). The inter-day relative errors and the inter-
day relative standard deviations and the recoveries obtained by
spiking blank samples at three different levels plus a zero level
are reported in Table 2.
5. Conclusion
This procedure (SALLE) afforded a convenient, selective, fast
and cost-saving operation with good cleanup ability for themodel analyte. The method involved a simple one-step solvent
extraction of atorvastatin from serum followed by salting out
the organic solvent using magnesium chloride. Salting out as-
sisted liquid–liquid extraction with acetonitrile is a greener
method and several samples can be extracted in parallel
(high-throughout sample preparation technique).
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